Back to search
FDAFDA · Food and drugs·Recall number D-0897-2017

Acyclovir Tablets, USP, 800 mg, 100-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, by Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-778-01

Published June 14, 2017 · Recall initiated: April 27, 2017

Summary

FDA records drug Class III recall D-0897-2017, published June 14, 2017 and initiated April 27, 2017. Recalling firm: Hetero USA Inc; Status: Terminated; Reported quantity: 13,692 bottles; Lot: Lot # ACY16075 Exp. 09/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: human hair melded into tablet.

What to do

Voluntary: Firm initiated · Letter

Get an email if ACYCLOVIR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ACYCLOVIR
Manufacturer
Hetero USA Inc
Distributor
Nationwide
UPC
0331722777018
Lot
Lot # ACY16075 Exp. 09/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Acyclovir Tablets, USP, 800 mg, 100-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, by Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-778-01 recalled?

Yes. FDA published recall D-0897-2017 on June 14, 2017. Reported hazard: Presence of Foreign Substance: human hair melded into tablet.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ACYCLOVIR. UPC: 0331722777018.